Global estimates of diabetes prevalence for 2013 and projections for 2035
- PMID:24630390
- DOI: 10.1016/j.diabres.2013.11.002
Global estimates of diabetes prevalence for 2013 and projections for 2035
Abstract
Introduction: Diabetes is a serious and increasing global health burden and estimates of prevalence are essential for appropriate allocation of resources and monitoring of trends.
Methods: We conducted a literature search of studies reporting the age-specific prevalence for diabetes and used the Analytic Hierarchy Process to systematically select studies to generate estimates for 219 countries and territories. Estimates for countries without available source data were modelled from pooled estimates of countries that were similar in regard to geography, ethnicity, and economic development. Logistic regression was applied to generate smoothed age-specific prevalence estimates for adults 20-79 years which were then applied to population estimates for 2013 and 2035.
Results: A total of 744 data sources were considered and 174 included, representing 130 countries. In 2013, 382 million people had diabetes; this number is expected to rise to 592 million by 2035. Most people with diabetes live in low- and middle-income countries and these will experience the greatest increase in cases of diabetes over the next 22 years.
Conclusion: The new estimates of diabetes in adults confirm the large burden of diabetes, especially in developing countries. Estimates will be updated annually including the most recent, high-quality data available.
Keywords: Ageing; Development; Diabetes; Prevalence; Urbanisation.
Copyright © 2013. Published by Elsevier Ireland Ltd.
Comment in
- Determinants of gender differences in the prevalence of diabetes.Guariguata L, Shaw JE, Whiting DW, Linnenkamp U.Guariguata L, et al.Diabetes Res Clin Pract. 2014 Nov;106(2):e14-6. doi: 10.1016/j.diabres.2014.08.008. Epub 2014 Aug 15.Diabetes Res Clin Pract. 2014.PMID:25204220No abstract available.
Similar articles
- IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.Whiting DR, Guariguata L, Weil C, Shaw J.Whiting DR, et al.Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. Epub 2011 Nov 12.Diabetes Res Clin Pract. 2011.PMID:22079683
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B.Cho NH, et al.Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26.Diabetes Res Clin Pract. 2018.PMID:29496507
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ.Sun H, et al.Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.Diabetes Res Clin Pract. 2022.PMID:34879977Free PMC article.
- Global rural diabetes prevalence: a systematic review and meta-analysis covering 1990-2012.Zabetian A, Sanchez IM, Narayan KM, Hwang CK, Ali MK.Zabetian A, et al.Diabetes Res Clin Pract. 2014 May;104(2):206-13. doi: 10.1016/j.diabres.2014.01.005. Epub 2014 Jan 14.Diabetes Res Clin Pract. 2014.PMID:24507869Review.
- Number of People with Type 2 Diabetes Mellitus in 2035 and 2050: A Modelling Study in 188 Countries.Guzman-Vilca WC, Carrillo-Larco RM.Guzman-Vilca WC, et al.Curr Diabetes Rev. 2024;21(1):e120124225603. doi: 10.2174/0115733998274323231230131843.Curr Diabetes Rev. 2024.PMID:38231048
Cited by
- A 16-year prospective cohort study to evaluate effects of long-term fluctuations in obesity indices of prediabetics on the incidence of future diabetes.Safari S, Abdoli M, Amini M, Aminorroaya A, Feizi A.Safari S, et al.Sci Rep. 2021 Jun 2;11(1):11635. doi: 10.1038/s41598-021-91229-9.Sci Rep. 2021.PMID:34079024Free PMC article.
- Obesity-induced taste dysfunction, and its implications for dietary intake.Harnischfeger F, Dando R.Harnischfeger F, et al.Int J Obes (Lond). 2021 Aug;45(8):1644-1655. doi: 10.1038/s41366-021-00855-w. Epub 2021 May 24.Int J Obes (Lond). 2021.PMID:34031530Review.
- Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older Chinese adults: a secondary analysis of a nationwide cohort.Peng J, Zhao F, Yang X, Pan X, Xin J, Wu M, Peng YG.Peng J, et al.BMJ Open. 2021 May 25;11(5):e042821. doi: 10.1136/bmjopen-2020-042821.BMJ Open. 2021.PMID:34035089Free PMC article.
- Monoamine Oxidases as Potential Contributors to Oxidative Stress in Diabetes: Time for a Study in Patients Undergoing Heart Surgery.Duicu OM, Lighezan R, Sturza A, Ceausu RA, Borza C, Vaduva A, Noveanu L, Gaspar M, Ionac A, Feier H, Muntean DM, Mornos C.Duicu OM, et al.Biomed Res Int. 2015;2015:515437. doi: 10.1155/2015/515437. Epub 2015 May 25.Biomed Res Int. 2015.PMID:26101773Free PMC article.Review.
- The use of adjustable gastric bands for management of severe and complex obesity.Hopkins JC, Blazeby JM, Rogers CA, Welbourn R.Hopkins JC, et al.Br Med Bull. 2016 Jun;118(1):64-72. doi: 10.1093/bmb/ldw012. Epub 2016 Mar 31.Br Med Bull. 2016.PMID:27034443Free PMC article.Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical